Most of the complete hematologic responses occurred at doses of dasatinib of 50 mg per day or more, whereas most cytogenetic responses required higher doses (Table 8 of the Supplementary Appendix).

After treatment with cetuximab (500 nM), dasatinib (50 nM) and their combination, cell lysates were incubated with the membrane. Thereafter, a cocktail of biotinylated detection antibodies, ...

and viability in the dasatinib insensitive MCF7 cell line, lowering the IC 50 of doxorubicin by more than one log unit. Additionally, combination treatment of dasatinib-sensitive MDA-MB-231 cells ...

Dasatinib was withheld again. After resolution of the second episode, dasatinib was reintroduced together with 50 mg of prednisone per day; no recurrence of panniculitis was noted, even when the ...

DASATINIB-TEVA contains the active ingredient ... The usual starting dose is 100 mg once daily (either as one 100 mg tablet or two 50 mg tablets). The entire dose of 100 mg is to be taken at ...

Dasatinib is a tyrosine kinase inhibitor and ... The usual starting dose is 100 mg once daily (either as one 100 mg tablet or two 50 mg tablets). The entire dose of 100 mg is to be taken at ...

Patients receive either 100 mg of dasatinib once daily or 50 mg twice daily. Thirty four patients had been on the clinical trial for at least three months when Atallah and lead researcher Jorge ...

"[Dasatinib] was effective and well tolerated ... received escalating doses up to 90 mg twice daily; dose reductions to 50 or 40 mg twice daily were allowed in patients experiencing adverse ...